You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 24, 2025

Drugs Containing Excipient (Inactive Ingredient) POLYETHYLENE GLYCOL 8000


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing POLYETHYLENE GLYCOL 8000 excipient, and estimated key patent expiration / generic entry dates

Generic drugs containing POLYETHYLENE GLYCOL 8000 excipient

Pharmaceutical Excipients: The Market Dynamics and Financial Trajectory of Polyethylene Glycol 8000

Introduction to Pharmaceutical Excipients

Pharmaceutical excipients are inert substances used as carriers or diluents for the active pharmaceutical ingredients (APIs) in drug formulations. They play a crucial role in enhancing the solubility, bioavailability, and stability of APIs, making them indispensable in modern drug development.

Overview of Polyethylene Glycol (PEG)

Polyethylene glycol (PEG) is a versatile excipient widely used in pharmaceutical formulations due to its unique properties. It is available in various molecular weights, such as PEG-400, PEG-600, PEG-4000, and PEG-8000, each with distinct applications.

Market Size and Growth of Pharmaceutical Excipients

The global pharmaceutical excipients market is experiencing robust growth. It is projected to grow from $9,728.83 billion in 2023 to $10,378.8 billion in 2024 at a CAGR of 6.7%, and further to $13,399.77 billion by 2028 at a CAGR of 6.6%[1].

Specific Focus on Polyethylene Glycol (PEG)

Market Size and Growth of PEG

The pharmaceutical grade polyethylene glycol market, which includes PEG-8000, was valued at USD 1,166.62 million in 2023 and is projected to reach USD 1,731.73 million by 2030, growing at a CAGR of 5.87% from 2024 to 2030[2].

Regional Analysis

The global PEG market is segmented into regions such as North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. Europe is currently the most lucrative region due to its well-established pharmaceutical industry and robust healthcare infrastructure. However, the Asia Pacific region is poised for rapid growth driven by the burgeoning pharmaceutical sector and increasing healthcare investments[2].

Applications of PEG-8000

Pharmaceutical Formulations

PEG-8000, with its higher molecular weight, is particularly suitable for various pharmaceutical applications, including sustained-release drug formulations and as a base for ointments and creams. Its use in advanced drug delivery systems, such as controlled-release medications, is a significant driver of market growth[2][4].

Personal Care and Industrial Applications

In addition to pharmaceuticals, PEG-8000 is used in personal care products due to its emollient and humectant properties. It also finds applications in industrial sectors as a stabilizer and thickener in food and beverage industries[4].

Key Trends and Drivers

Technological Advancements

Technological advancements in drug delivery systems and global growth in pharmaceutical research and development are key drivers of the PEG market. Innovations in production techniques are improving product efficiency and environmental compatibility[2][4].

Sustainability Focus

There is an increasing focus on eco-friendly and biodegradable polyethylene glycol formulations to meet environmental regulations and consumer preferences. This trend is expected to shape the industry significantly in the coming years[4].

Regulatory Compliance

Regulatory compliance and quality standards are major trends in the pharmaceutical excipients market. Manufacturers are prioritizing compliance with stringent regulatory requirements, which is driving the demand for high-quality excipients like PEG-8000[5].

Financial Trajectory

Current Valuation

The pharmaceutical grade PEG market, including PEG-8000, is valued at USD 1,166.62 million in 2023 and is expected to grow significantly over the next few years[2].

Future Projections

By 2030, the market is projected to reach USD 1,731.73 million, growing at a CAGR of 5.87% from 2024 to 2030. This growth is underpinned by robust demand in pharmaceuticals, personal care, and industrial applications, as well as increasing investments in research and development[2].

Regional Growth

The Asia Pacific region is expected to exhibit compelling growth prospects, driven by the burgeoning pharmaceutical sector, increasing healthcare investments, and a rapidly evolving market landscape. North America and Europe will also remain key hubs for R&D activities and market growth[2][4].

Challenges and Restraints

Raw Material Price Volatility

Fluctuating prices of ethylene oxide, a key raw material for PEG production, can impact manufacturing costs and pose a challenge to market growth[4].

Stringent Regulations

Compliance with stringent regulatory standards can be a restraint, but it also drives the demand for high-quality excipients like PEG-8000, ensuring that the market remains competitive and innovative[4].

Industry Expert Insights

"The polyethylene glycol market is experiencing a transformative phase driven by increasing applications in pharmaceuticals, personal care, and industrial sectors. Robust R&D and demand from emerging economies are expected to solidify its growth trajectory," says an industry expert, highlighting the dynamic nature of the PEG market[4].

Key Takeaways

  • Market Growth: The pharmaceutical grade PEG market, including PEG-8000, is expected to grow from USD 1,166.62 million in 2023 to USD 1,731.73 million by 2030 at a CAGR of 5.87%.
  • Applications: PEG-8000 is used in sustained-release drug formulations, ointments, creams, personal care products, and industrial applications.
  • Regional Growth: Europe is the current leader, but the Asia Pacific region is poised for rapid growth.
  • Trends: Technological advancements, sustainability focus, and regulatory compliance are key trends driving the market.
  • Challenges: Raw material price volatility and stringent regulations are significant challenges.

FAQs

Q: What is the projected growth rate of the pharmaceutical grade PEG market from 2024 to 2030?

A: The pharmaceutical grade PEG market is projected to grow at a CAGR of 5.87% from 2024 to 2030[2].

Q: Which region is expected to show the fastest growth in the PEG market?

A: The Asia Pacific region is expected to exhibit the fastest growth due to the burgeoning pharmaceutical sector and increasing healthcare investments[2].

Q: What are the primary applications of PEG-8000 in the pharmaceutical industry?

A: PEG-8000 is primarily used in sustained-release drug formulations and as a base for ointments and creams[2].

Q: What are the key trends driving the growth of the PEG market?

A: Technological advancements, sustainability focus, and regulatory compliance are key trends driving the market[2][4].

Q: What challenges might affect the growth of the PEG market?

A: Raw material price volatility and stringent regulations are significant challenges that might affect market growth[4].

Sources

  1. Pharmaceutical Excipients Global Market Report 2024 - ResearchAndMarkets
  2. Pharmaceutical Grade Polyethylene Glycol (PEG) Market Size And Forecast - Verified Market Research
  3. Understanding the Future of Pharmaceutical Excipients - BCC Research
  4. Polyethylene Glycol Market Trends Highlight Robust Demand - GlobeNewswire
  5. Organic Pharmaceutical Excipients Global Market Report 2024 - The Business Research Company

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.